Four years ago, the startup Nabi Biopharmaceuticals began testing a promising nicotine vaccine called NicVax with the aid of $4.1 million in funding from the National Institutes of Health. Earlier today, the vaccine received a booster ...READ»
ADVERTISEMENT
